Evra patch: weekly changes, a lifted patch and the risk of clots
Evra is a combined hormonal contraceptive patch that releases norelgestromin and ethinylestradiol through the skin, so you change a patch once a week instead of taking a daily tablet. This page sets out the four-week cycle described in the product information, what to do when a patch lifts or a change is late, how the risk of blood clots compares with other methods and what the doctor checks before prescribing it.
What Evra contains and how it prevents pregnancy
Evra is a transdermal patch, which means it releases medicine through the skin. It contains two hormones: norelgestromin, a progestogen, and ethinylestradiol, an oestrogen. According to the product information, each 20 cm² patch contains 6 mg of norelgestromin and 600 micrograms of ethinylestradiol and releases on average 203 micrograms and 33.9 micrograms of them every 24 hours.
Because it contains both hormones, Evra belongs to the combined hormonal contraceptives, the same group as the combined pill and the vaginal ring, and the same precautions apply. Its main action is to stop ovulation, the monthly release of an egg; changes to the mucus at the entrance to the womb and to the lining of the womb may also contribute.
The combined pill is described on our page on Yasmin and the vaginal ring on our page on NuvaRing. An overview of the methods, and of what the doctor checks for each of them, is on our contraception page.
Who the patch is meant for
The authorised use is contraception in women of fertile age. Safety and efficacy were established in women aged 18 to 45. The product information states that Evra is not intended for women after the menopause, is not a hormone replacement therapy and has not been shown to be safe and effective in girls under 18.
Before prescribing it, the prescriber is asked to weigh your current risk factors, particularly those for blood clots in the veins, and how the clot risk with Evra compares with other combined methods. The patch may suit you if remembering a daily tablet is difficult, but it has to stay stuck to your skin and you check it every day.
Contraceptive efficacy may be reduced if you weigh 90 kg or more. Evra does not protect against HIV or other sexually transmitted infections; a condom can be used alongside it.
The four-week cycle: when you change the patch
You wear one patch at a time. The day you put on your first patch becomes your Change Day, and every later patch goes on the same day of the week, at any time of that day. The product information sets out the cycle as follows.
| Day of the cycle | What you do |
|---|---|
| Day 1 | Apply the first patch and wear it for one full week |
| Day 8 | Remove it and apply a new patch on your Change Day |
| Day 15 | Remove it and apply a new patch on your Change Day |
| Day 22 | Remove the third patch; the fourth week is patch-free |
| The day after the patch-free week | Apply a new patch to start the next cycle, even if there has been no bleed or the bleed has not stopped |
Never more than seven patch-free days
The product information is firm on one point: there should never be more than seven patch-free days in a row between cycles. If the gap is longer, you may not be protected against pregnancy and you use a non-hormonal method, such as condoms, for seven days. The risk of ovulation rises with each extra day, and if you have had sex during such a longer gap, the possibility of pregnancy should be considered.
You can delay a period for one cycle by applying another patch on Day 22 instead of having the patch-free week. Spotting or breakthrough bleeding may occur, and after six weeks in a row of wearing patches a seven-day patch-free interval follows. The leaflet asks you to talk to a doctor before deciding to delay a period. If you want to move your Change Day, you finish the current cycle first and choose the new day during the patch-free week.
Where and how you apply it
The product information lists clean, dry, hairless and healthy skin on the buttock, abdomen, upper outer arm or upper torso, in a place where tight clothing will not rub it. The patch does not go on the breasts or on skin that is red, irritated or cut. Put each new patch in a different spot to help avoid irritation; you can stay within the same area of the body.
Press the patch down firmly until the edges stick well, and look at it every day. Do not put make-up, creams, lotions, powders or other skin products on the area where the patch is or where you will put the next one, because they can stop it sticking. Do not cut, damage or alter a patch, as this may reduce its effect.
If a patch irritates your skin, you may take it off and put a new one in a different place until your next Change Day, still wearing only one at a time. Used patches are thrown away carefully, as the leaflet describes.
Starting Evra or switching to it
If you have not used hormonal contraception in the previous cycle, you start on the first day of your period. If you start later in that cycle, the product information asks you to use a non-hormonal method as well for the first seven days of the first cycle only.
If you are switching from a combined pill, you start on the first day of the withdrawal bleed. If you start later than that, you use a non-hormonal method for seven days, and if there is no bleed within five days of the last active tablet, pregnancy must be ruled out first. You can switch from a progestogen-only pill on any day, with a barrier method for the first seven days.
After childbirth, if you are not breast-feeding, the patch is started no sooner than four weeks after the birth. Whether and when you start is part of the doctor's assessment, and the leaflet in the pack gives the details for your situation.
If a patch comes off or a change is late
A patch that lifts at the edges or comes off delivers less hormone. What to do depends on how long it was off and where you are in the cycle. Section 4.2 of the product information gives these instructions:
| Situation | What the product information says |
|---|---|
| Partly or completely off for less than 24 hours | Re-apply it in the same place, or apply a new patch at once if it no longer sticks; no extra contraception is needed and your Change Day stays the same |
| Off for 24 hours or more, or you do not know when it lifted | You may not be protected: start a new cycle at once with a new patch, which gives you a new Day 1 and Change Day, and use a non-hormonal method for the first seven days |
| First patch of a new cycle applied late | You may not be protected: apply it as soon as you remember, count a new Day 1 and use a non-hormonal method for seven days |
| Change on Day 8 or Day 15 late by up to 48 hours | Apply a new patch at once and keep your usual Change Day; no extra method is needed if the patch was worn correctly in the seven days before |
| Change on Day 8 or Day 15 late by 48 hours or more | You may not be protected: start a new four-week cycle at once with a new patch and use a non-hormonal method for seven days |
| Third patch not removed on Day 22 | Remove it as soon as possible and start the next cycle on your usual Change Day; no extra method is needed |
What not to do with a patch that has lifted
Do not hold a lifted patch in place with tape, plasters or a bandage, and do not re-apply a patch that is no longer sticky; put on a new one instead. Never wear two patches at the same time. If you are unsure how long a patch was off, the product information treats not knowing in the same way as 24 hours or more.
If you have had sex during a time when you may not have been protected, ask a pharmacist or a doctor promptly whether emergency contraception is needed, because the timing matters. Emergency contraception is not part of our Contraception service. The same way of thinking about a gap in protection is explained for tablets in our guide to a missed contraceptive pill.
Bath, shower, sauna and an upset stomach
According to the package leaflet, normal activities such as a bath or shower, a sauna and exercise should not affect how well the patch works, and the patch is designed to stay in place during them. Check afterwards that it has not come off.
The leaflet also says that being sick or having diarrhoea should not affect the amount of hormone you get from the patch, so an upset stomach on its own does not mean you need extra contraception. That is one practical difference from a tablet, which can be lost through vomiting.
How large the risk of blood clots is
Every combined hormonal contraceptive raises the risk of venous thromboembolism (VTE), a clot in a vein, usually in the leg, which can travel to the lungs. The product information gives these estimates for one year of use:
| Group of women | Estimated VTE cases per 10,000 women in one year |
|---|---|
| Not using combined hormonal contraception and not pregnant | About 2 |
| Using a low-dose combined product containing levonorgestrel | About 5 to 7 |
| Using Evra | About 6 to 12 |
What these numbers mean for you
Products containing levonorgestrel, norgestimate or norethisterone are associated with the lowest risk of VTE, and studies suggest that the risk with Evra is up to twice as high as with levonorgestrel products. The product information says that a product other than one with the lowest risk should be chosen only after a discussion that makes sure you understand this.
Your risk is highest in the first year of use, and there is some evidence that it rises again when you restart after a break of four weeks or more. In both cases the yearly number is lower than the number expected during pregnancy or in the weeks after childbirth. VTE may be fatal in 1 to 2% of cases. The risk rises further with other risk factors, and several together can raise it by more than the sum of each.
- Obesity, with a body mass index over 30 kg/m², the risk rising as the BMI rises
- Prolonged immobilisation, major surgery, surgery to the legs or pelvis, neurosurgery or major trauma; the product information advises stopping the patch at least four weeks before planned surgery and restarting only two weeks after you are fully mobile again
- Temporary immobilisation, including air travel of more than four hours, particularly with other risk factors
- A clot in a brother, sister or parent at a relatively early age
- Increasing age, particularly over 35
- Other conditions such as cancer, systemic lupus erythematosus, haemolytic uraemic syndrome, Crohn's disease, ulcerative colitis and sickle cell disease
- Pregnancy and the six weeks after childbirth
Clots in arteries, smoking and migraine
The same group of medicines is linked with a higher risk of clots in arteries, which can cause a heart attack or a stroke. Increasing age, particularly over 35, smoking, high blood pressure, obesity, migraine, diabetes, heart valve disease, atrial fibrillation and a family history of such clots add to that risk.
The product information advises women who want to use a combined method not to smoke, and strongly advises women over 35 who continue to smoke to use a different method of contraception. A migraine that becomes more frequent or more severe while you use the patch may be an early sign of a problem with the blood supply to the brain and may be a reason to stop it at once, so contact a doctor promptly.
Warning signs: when you need urgent help
Seek urgent medical help, and tell the healthcare professional that you use a combined hormonal contraceptive, if you notice any of the signs below. In an emergency, call 112. Some of these symptoms, such as breathlessness or a cough, are easy to mistake for something milder, which is why the product information lists them.
- Swelling of one leg or along a vein in the leg, pain or tenderness in the leg that may be felt only when standing or walking, warmth, or red or discoloured skin on the leg
- Sudden unexplained breathlessness or fast breathing, a sudden cough that may bring up blood, sharp chest pain, severe light-headedness or dizziness, or a fast or irregular heartbeat
- Pain, pressure, heaviness or tightness in the chest, arm or below the breastbone, sometimes spreading to the back, jaw, throat or stomach, with sweating, nausea or shortness of breath
- Sudden numbness or weakness of the face, arm or leg, especially on one side, sudden confusion, trouble speaking, walking or seeing, or a sudden, severe or prolonged headache with no known cause
- Blurred vision that may progress to loss of vision
- Severe pain in the upper abdomen
Who should not use Evra
The product information lists conditions in which combined hormonal contraceptives should not be used. If one of them appears while you use the patch, it is stopped at once. The doctor weighs these before prescribing, so answer the questionnaire carefully and completely.
- A current or past clot in a vein, such as deep vein thrombosis or pulmonary embolism, or a known inherited or acquired tendency to such clots
- Major surgery with prolonged immobilisation, or several risk factors together that make the risk of a clot high
- A current or past heart attack, angina, stroke or transient ischaemic attack, or a known tendency to clots in arteries
- A history of migraine with focal neurological symptoms (migraine with aura)
- Diabetes with damage to the blood vessels, severe high blood pressure or a severe disorder of blood fats
- Known or suspected breast cancer, cancer of the lining of the womb or another oestrogen-dependent cancer
- Liver disease with abnormal liver function, or a liver tumour
- Vaginal bleeding that has not been explained
- Allergy to the active substances or to any other ingredient
- Hepatitis C treatment with ombitasvir, paritaprevir and ritonavir with dasabuvir, with glecaprevir and pibrentasvir, or with sofosbuvir, velpatasvir and voxilaprevir
Mood, blood pressure and other precautions
Depressed mood and depression are well-known side effects of hormonal contraception, and the product information notes that depression can be serious and is a well-known risk factor for suicidal behaviour and suicide. Contact a doctor if your mood changes or you notice symptoms of depression, including soon after you start. If you have thoughts of harming yourself, please seek help. In an emergency, call 112. Supportline 179 (Appoġġ): 24/7, free from landlines and mobiles. Richmond Foundation helpline 1770: Monday to Friday 8 am to 8 pm, Saturday until 4 pm.
Small rises in blood pressure are reported in many women who use hormonal contraceptives. If your blood pressure stays high despite treatment, the combined method is stopped. Before you start or restart, the product information recommends a complete medical history including your family history, ruling out pregnancy, a blood pressure measurement and an examination guided by the contraindications. That is why the doctor may ask you for a recent blood pressure reading.
Other points from the product information: women with high triglycerides, or a family history of them, may have a higher risk of pancreatitis; women with diabetes should be observed carefully, particularly early on; and brownish patches on the face (chloasma) can occur, so if you are prone to them you avoid sun and ultraviolet light.
Irregular bleeding or spotting is common in the first months, so a medical opinion on it is useful after about three cycles. If you miss a withdrawal bleed after using the patch as directed, pregnancy is unlikely; if you did not use it as directed, or two bleeds are missed, pregnancy must be ruled out before you continue.
Medicines that can interact with Evra
Some medicines speed up the breakdown of the hormones in the liver and can make the patch less reliable or cause breakthrough bleeding. The product information names barbiturates, bosentan, carbamazepine, phenytoin, primidone, rifampicin and modafinil, the HIV medicines ritonavir, nevirapine and efavirenz, and possibly felbamate, griseofulvin, oxcarbazepine, topiramate and the herbal remedy St John's wort. During a short course of such a medicine and for 28 days after it, a barrier method is used as well; with long-term treatment, another reliable non-hormonal method is recommended.
The hepatitis C combinations listed above must not be used with the patch: you switch to another method before starting them and can restart Evra two weeks after finishing. Combined hormonal contraceptives can lower the level of lamotrigine, an epilepsy medicine, which may reduce seizure control, and can raise the level of ciclosporin. Etoricoxib can raise the level of ethinylestradiol. Tell the doctor about every medicine you take, including herbal products and supplements.
Side effects listed in the product information
In the clinical trials, the most common side effects were headache, nausea and breast tenderness, reported by about 21.0%, 16.6% and 15.9% of women respectively. Spotting, breast tenderness and nausea may occur at the start and usually lessen after the first three cycles. Reactions where the patch sits are the complaint most specific to this form, and putting each patch in a different spot helps.
| How often | Examples from the product information |
|---|---|
| Very common (more than 1 in 10) | Headache, nausea, breast tenderness |
| Common (up to 1 in 10) | Redness, irritation, itching or rash where the patch sits, mood, affect and anxiety disorders, migraine, dizziness, abdominal pain, vomiting, diarrhoea, acne, weight gain, vaginal thrush, painful periods, muscle spasms, tiredness |
| Uncommon (up to 1 in 100) | High blood pressure, sleeplessness, reduced sex drive, hair loss, raised cholesterol, fluid retention, eczema |
| Rare (up to 1 in 1,000) | Clots in veins or arteries, including pulmonary embolism, heart attack and stroke, inflammation of the gallbladder, gallstones, liver tumours |
Pregnancy, breast-feeding and after childbirth
Evra is not used during pregnancy, and if you become pregnant while using it, you stop it at once. The product information states that studies show no increased risk of birth defects in children of women who used combined pills before pregnancy, and that data on pregnancies exposed to the patch are too limited to draw conclusions.
Combined hormonal contraceptives may reduce the amount of breast milk and change its composition, so the product information does not recommend Evra until you have completely weaned your baby. If you are not breast-feeding, you start no sooner than four weeks after the birth, and the higher risk of clots after childbirth is taken into account. After you stop the patch, it may take a little longer to become pregnant.
Prescription status of Evra in Malta
Evra is authorised centrally for the whole European Union, under EMA product number EMEA/H/C/000410. Annex II of its product information classes it as a medicinal product subject to medical prescription, which applies in Malta as in the other member states. Because the authorisation is European, the Medicines Authority register has no separate national entry for Evra.
How the doctor assesses a request for the patch
You fill in a medical questionnaire about the medicine, your health and other medicines you take, whether you want to start the patch, continue it or switch to it from another method. The doctor reviews your answers in writing and weighs the same risk factors as for any combined method. The doctor may ask you for a recent blood pressure reading, suggest a different method, recommend that you see a doctor in Malta or decline.
If the doctor has questions, they ask them in writing in the chat in your account, and you get an email to let you know. There is no video call, no phone call and no live chat. For some conditions, and in some individual cases, it is advisable to see a doctor in person; the doctor may recommend this. New symptoms, above all the warning signs listed above, need a doctor who can examine you.
If the doctor issues a prescription, you receive it as a PDF by email. You print it and bring it on paper to a pharmacy in Malta together with photo identification. Your prescription is issued in the standard EU cross-border format set out in Directive 2012/52/EU. A pharmacy in Malta may dispense it; the decision rests with the pharmacist. Take the prescription to a pharmacy within six months of the date on it; a prescription for an antibiotic cannot be dispensed more than ten days after its date of issue.
What does it cost?
Two separate costs are involved. The button on this page shows the fee for the doctor's review, and the patches themselves are paid for at the pharmacy, which can tell you the price of the pack. It is not an ePrescription and does not appear in myHealth; it is outside POYC and the Government Formulary List, and you pay for the medicine at the pharmacy in full.
The fee covers the medical consultation, not the issuing of a document. If the doctor declines on medical or legal grounds, we refund the fee. If the doctor asks you for documents, you have at least 7 days to send them in and we send you a reminder; if you ask us, we agree a longer deadline. If the case still cannot be completed, we close the request, let you know and refund the fee in full.
Who reviews your request?
Your request is reviewed by Damian Wojno, a doctor registered with the Polish Medical Chamber, licence no. 3211301. The doctor is not registered with the Medical Council of Malta.
Is Evra prescription-only in Malta?
Evra is authorised centrally in the European Union, and Annex II of its product information classes it as a medicinal product subject to medical prescription, which applies in Malta as in the other member states. It has no separate national entry in the Medicines Authority register, because its authorisation is European. A doctor decides whether it suits you after weighing up your blood pressure, your personal and family history of clots and the other medicines you take.
How often do you change the Evra patch?
Once a week for three weeks, always on the same day of the week, your Change Day: you apply the first patch on Day 1 and change it on Day 8 and Day 15, then remove it on Day 22 for a patch-free week. The next patch goes on the day after that week, even if a bleed has not started or has not stopped. There should never be more than seven patch-free days in a row.
What should you do if the Evra patch falls off?
If it has been off for less than 24 hours, the product information says to re-apply it in the same place, or apply a new one if it no longer sticks, with no extra contraception and the same Change Day. If it has been off for 24 hours or more, or you do not know when it came off, you may not be protected: you start a new cycle with a new patch and use a non-hormonal method for seven days. Do not use tape or a bandage to hold it in place.
Can you have a bath, shower or sauna with the Evra patch?
The package leaflet says that a bath or shower, a sauna and exercise should not affect how well the patch works, and that the patch is designed to stay in place during these activities. Check afterwards that it has not come off, and keep creams, lotions, oils and powders away from the skin where the patch sits, because they can stop it sticking.
Does Evra work if you weigh 90 kg or more?
The product information states that contraceptive efficacy may be reduced in women weighing 90 kg or more, so at that weight the doctor may suggest a different method. Obesity, with a body mass index over 30, is also listed as a risk factor for blood clots with combined hormonal contraception, which is another reason your weight is part of the assessment.
What are the most common side effects of Evra?
In the clinical trials, headache, nausea and breast tenderness were the most common, reported by about 21.0%, 16.6% and 15.9% of women. Skin reactions where the patch sits are also common, and putting each patch in a different spot helps. Spotting, breast tenderness and nausea often appear at the start and usually lessen after the first three cycles. Pain or swelling in one leg, sudden breathlessness, chest pain or a sudden severe headache need urgent medical help.
Can you use Evra while breast-feeding?
The product information does not recommend Evra until you have completely weaned your baby, because combined hormonal contraceptives may reduce the amount of breast milk and change its composition. If you are not breast-feeding, the patch is started no sooner than four weeks after the birth. The doctor can discuss which method suits you while you are breast-feeding.
Can a pharmacy in Malta dispense a prescription from a doctor in another EU country?
A prescription from a doctor in another EU country can be dispensed in Malta (Article 81(3) of the Medicines Act, Cap. 458) if the pharmacist can confirm the doctor's licence. The decision rests with the pharmacist, who may refuse. You bring the prescription on paper together with photo identification.
- EMA: Evra, European public assessment report (EMEA/H/C/000410)
- EMA: Evra product information (summary of product characteristics, Annex II and package leaflet)
- Medicines Authority: prescription-only and non-prescription medicines
- Medicines Act (Cap. 458), Article 81 (legislation.mt)
- Prescription and Dispensing Requirements Rules (S.L. 458.49), rule 4 (legislation.mt)
- Commission Implementing Directive 2012/52/EU on the recognition of medical prescriptions issued in another Member State (EUR-Lex)